Tag Archives: WashU

AI-based breast cancer risk technology receives FDA Breakthrough Device designation – WashU Medicine

AI-based breast cancer risk technology receives FDA Breakthrough Device designation – WashU Medicine

Visit the News Hub Software developed at WashU Medicine on accelerated path to approval Getty Images A new AI-based technology developed at WashU Medicine analyzes mammograms to provide a more accurate prediction of an individual’s risk of developing breast cancer over the next five years. The software has now received the FDA’s Breakthrough Device designation. A new technology that harnesses …

Read More »